Correlation Between Emergent Biosolutions and Cocrystal Pharma

Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Biosolutions and Cocrystal Pharma, you can compare the effects of market volatilities on Emergent Biosolutions and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Cocrystal Pharma.

Diversification Opportunities for Emergent Biosolutions and Cocrystal Pharma

0.1

Correlation Coefficient

Emergent Biosolutions  Cocrystal Pharma

Average diversification

The 3 months correlation between Emergent and Cocrystal is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Cocrystal Pharma go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Cocrystal Pharma

Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Cocrystal Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Emergent Biosolutions is 2.06 times less risky than Cocrystal Pharma. The stock trades about -0.36 of its potential returns per unit of risk. The Cocrystal Pharma is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  217.00  in Cocrystal Pharma on September 25, 2024 and sell it today you would earn a total of  52.00  from holding Cocrystal Pharma or generate 23.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Emergent Biosolutions  vs.  Cocrystal Pharma

Emergent Biosolutions

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cocrystal Pharma

Risk-Adjusted Performance

12 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cocrystal Pharma are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady fundamental indicators, Cocrystal Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Emergent Biosolutions and Cocrystal Pharma

The main advantage of trading using opposite Emergent Biosolutions and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.

The idea behind Emergent Biosolutions and Cocrystal Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.